162 related articles for article (PubMed ID: 36964913)
21. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
[TBL] [Abstract][Full Text] [Related]
22. Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.
Weber T; Schilling T; Frank-Raue K; Colombo-Benkmann M; Hinz U; Ziegler R; Klar E
Surgery; 2001 Dec; 130(6):1044-9. PubMed ID: 11742336
[TBL] [Abstract][Full Text] [Related]
23. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
[TBL] [Abstract][Full Text] [Related]
24. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests.
Scheuba C; Kaserer K; Weinhäusl A; Pandev R; Kaider A; Passler C; Prager G; Vierhapper H; Haas OA; Niederle B
Surgery; 1999 Dec; 126(6):1089-95; discussion 1096. PubMed ID: 10598192
[TBL] [Abstract][Full Text] [Related]
25. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
[TBL] [Abstract][Full Text] [Related]
26. Micromedullary thyroid cancer: how micro is truly micro?
Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
[TBL] [Abstract][Full Text] [Related]
27. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
Samulski TD; Livolsi VA; Montone K; Baloch Z
Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
[TBL] [Abstract][Full Text] [Related]
28. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC).
Cohen R; Campos JM; Salaün C; Heshmati HM; Kraimps JL; Proye C; Sarfati E; Henry JF; Niccoli-Sire P; Modigliani E
J Clin Endocrinol Metab; 2000 Feb; 85(2):919-22. PubMed ID: 10690910
[TBL] [Abstract][Full Text] [Related]
29. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
Gimm O; Ukkat J; Dralle H
World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
[TBL] [Abstract][Full Text] [Related]
30. Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.
Hinze R; Holzhausen HJ; Gimm O; Dralle H; Rath FW
Virchows Arch; 1998 Sep; 433(3):203-8. PubMed ID: 9769122
[TBL] [Abstract][Full Text] [Related]
31. Medullary thyroid cancer: prognostic factors for survival and recurrence, recommendations for the extent of lymph node dissection and for surgical therapy in recurrent disease.
Pilaete K; Delaere P; Decallonne B; Bex M; Hauben E; Nuyts S; Clement P; Hermans R; Vander Poorten V
B-ENT; 2012; 8(2):113-21. PubMed ID: 22896930
[TBL] [Abstract][Full Text] [Related]
32. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.
Yen TW; Shapiro SE; Gagel RF; Sherman SI; Lee JE; Evans DB
Surgery; 2003 Dec; 134(6):890-9; discussion 899-901. PubMed ID: 14668720
[TBL] [Abstract][Full Text] [Related]
33. Early postoperative calcitonin-to-preoperative calcitonin ratio as a predictive marker for structural recurrence in sporadic medullary thyroid cancer: A retrospective study.
Jiao Z; Wu T; Jiang M; Jiang S; Jiang K; Peng J; Luo G; Yu Y; Chen W; Yang A
Front Endocrinol (Lausanne); 2022; 13():1094242. PubMed ID: 36589824
[TBL] [Abstract][Full Text] [Related]
34. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.
Ahmed SR; Ball DW
J Clin Endocrinol Metab; 2011 May; 96(5):1237-45. PubMed ID: 21346073
[TBL] [Abstract][Full Text] [Related]
35. Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule.
Fukushima M; Ito Y; Hirokawa M; Miya A; Kobayashi K; Akasu H; Shimizu K; Miyauchi A
World J Surg; 2009 May; 33(5):963-8. PubMed ID: 19198929
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
37. Exceptionality of Distant Metastasis in Node-Negative Hereditary and Sporadic Medullary Thyroid Cancer: Lessons Learned.
Machens A; Lorenz K; Weber F; Dralle H
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2968-e2979. PubMed ID: 33788951
[TBL] [Abstract][Full Text] [Related]
38. Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.
Torresan F; Mian C; Cavedon E; Iacobone M
Langenbecks Arch Surg; 2019 Jun; 404(4):411-419. PubMed ID: 30903267
[TBL] [Abstract][Full Text] [Related]
39. [Decision making in postoperative incidentally found small C-cell-carcinoma].
Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
[TBL] [Abstract][Full Text] [Related]
40. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
